{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:49:25Z","timestamp":1793306965367,"version":"4.5.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"9","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.autrev.2013.03.007","type":"journal-article","created":{"date-parts":[[2013,3,25]],"date-time":"2013-03-25T15:12:36Z","timestamp":1364224356000},"page":"875-884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":329,"title":["The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes"],"prefix":"10.1016","volume":"12","author":[{"given":"Alexander","family":"Marx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Schalke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcher","family":"Saruhan-Direskeneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Melms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Str\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2013.03.007_bb0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/WCO.0b013e32833cc968","article-title":"Autoimmune mediated neuromuscular junction defects","volume":"23","author":"Farrugia","year":"2010","journal-title":"Curr Opin Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2013.03.007_bb0010","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1007\/s10875-010-9401-x","article-title":"Autoimmune channelopathies: well-established and emerging immunotherapy-responsive diseases of the peripheral and central nervous systems","volume":"30","author":"Vincent","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/08916930903555935","article-title":"Thymoma and paraneoplastic myasthenia gravis","volume":"43","author":"Marx","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2013.03.007_bb0020","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.autrev.2013.03.007_bb0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2013.03.007_bb0030","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0045","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.autrev.2013.03.002","article-title":"Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens","volume":"12","author":"Zisimopoulou","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2013.03.007_bb0050","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ana.23691","article-title":"Risk for myasthenia gravis maps to a (151) Pro-->Ala change in TNIP1 and to human leukocyte antigen-B*08","volume":"72","author":"Gregersen","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0055","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2013.03.007_bb0060","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0065","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/WCO.0b013e328357a829","article-title":"Autoimmune mechanisms in myasthenia gravis","volume":"25","author":"Cavalcante","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0075","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/mus.23271","article-title":"Geographical distribution of a seropositive myasthenia gravis population","volume":"45","author":"Heldal","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2013.03.007_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.autrev.2013.03.007_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/08916934.2011.622015","article-title":"Myasthenogenicity of the main immunogenic region and endogenous muscle nicotinic acetylcholine receptors","volume":"45","author":"Luo","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2013.03.007_bb0090","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.77.2.755","article-title":"Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits","volume":"77","author":"Tzartos","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2013.03.007_bb0095","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/35097557","article-title":"Induction, assembly, maturation and maintenance of a postsynaptic apparatus","volume":"2","author":"Sanes","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.autrev.2013.03.007_bb0100","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0002-9440(10)65225-X","article-title":"Establishment of a human thymic myoid cell line. Phenotypic and functional characteristics","volume":"155","author":"Wakkach","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0105","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.410220205","article-title":"Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study","volume":"22","author":"Schluep","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0110","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1167\/iovs.06-0073","article-title":"Identification of acetylcholine receptor subunits differentially expressed in singly and multiply innervated fibers of extraocular muscles","volume":"47","author":"Fraterman","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2013.03.007_bb0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1212\/WNL.41.1.128","article-title":"Absence of acetylcholine-induced current in epithelial cells from thymus glands and thymomas of myasthenia gravis patients","volume":"41","author":"Siara","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.007_bb0120","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.4049\/jimmunol.174.10.5941","article-title":"Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis","volume":"174","author":"Poea-Guyon","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0125","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nature06066","article-title":"An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus","volume":"448","author":"Giraud","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2013.03.007_bb0130","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2353\/ajpath.2007.070240","article-title":"Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status","volume":"171","author":"Leite","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/jnnp-2011-301046","article-title":"Impact commentaries. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"83","author":"Vincent","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2013.03.007_bb0140","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2013.03.007_bb0145","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of maysthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-like protein 4","volume":"12","author":"Verschuuren","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.007_bb0150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0165-2478(94)90168-6","article-title":"Response to human acetylcholine receptor alpha 138\u2013199: determinant spreading initiates autoimmunity to self-antigen in rabbits","volume":"39","author":"Vincent","year":"1994","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2013.03.007_bb0155","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199902)45:2<224::AID-ANA13>3.0.CO;2-B","article-title":"Early-onset myasthenia gravis: a recurring T-cell epitope in the adult-specific acetylcholine receptor epsilon subunit presented by the susceptibility allele HLA-DR52a","volume":"45","author":"Hill","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0165-5728(01)00272-7","article-title":"Presentation by myoblasts of an epitope from endogenous acetylcholine receptor indicates a potential role in the spreading of the immune response","volume":"115","author":"Curnow","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2008.06.016","article-title":"Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis","volume":"201\u2013202","author":"Maclennan","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0170","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.4049\/jimmunol.166.10.6430","article-title":"Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis","volume":"166","author":"Wang","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0175","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/310244a0","article-title":"Autoimmune human T lymphocytes specific for acetylcholine receptor","volume":"310","author":"Hohlfeld","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2013.03.007_bb0180","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1172\/JCI2068","article-title":"A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4-producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes","volume":"101","author":"Nagvekar","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.03.007_bb0185","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.41.8.1270","article-title":"Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients","volume":"41","author":"Sommer","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.007_bb0190","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ana.410310314","article-title":"T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit","volume":"31","author":"Melms","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1196\/annals.1405.021","article-title":"Autoimmunizing mechanisms in thymoma and thymus","volume":"1132","author":"Willcox","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.007_bb0200","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1196\/annals.1254.026","article-title":"Scenarios for autoimmunization of T and B cells in myasthenia gravis","volume":"998","author":"Shiono","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.007_bb0205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ni1444","article-title":"Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells","volume":"8","author":"Aschenbrenner","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0210","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.autrev.2013.03.007_bb0215","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.autrev.2011.05.004","article-title":"Human FoxP3+ regulatory T cells in systemic autoimmune diseases","volume":"10","author":"Miyara","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.007_bb0220","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.03.007_bb0225","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2010.03.016","article-title":"Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients","volume":"225","author":"Masuda","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0230","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4049\/jimmunol.0802046","article-title":"Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients","volume":"183","author":"Luther","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0235","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/mus.23488","article-title":"Granulocyte macrophage colony-stimulating factor treatment of a patient in myasthenic crisis: effects on regulatory T cells","volume":"46","author":"Rowin","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2013.03.007_bb0240","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clim.2008.03.509","article-title":"Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis","volume":"128","author":"Sheng","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0245","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/ana.20340","article-title":"Selective loss of regulatory T cells in thymomas","volume":"56","author":"Strobel","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0250","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2005.03.011","article-title":"Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma","volume":"164","author":"Luther","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0255","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s10875-007-9147-2","article-title":"Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy","volume":"28","author":"Fattorossi","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0260","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood.V100.1.159","article-title":"Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas","volume":"100","author":"Strobel","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.03.007_bb0265","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.expneurol.2009.09.022","article-title":"T-bet deficiency decreases susceptibility to experimental myasthenia gravis","volume":"220","author":"Liu","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0270","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2011.10.010","article-title":"GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis","volume":"240\u2013241","author":"Sheng","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0275","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/path.2141","article-title":"Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1)","volume":"211","author":"Strobel","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0280","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2249.2007.03442.x","article-title":"Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas","volume":"149","author":"Scarpino","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0285","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.4049\/jimmunol.178.2.1208","article-title":"A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"178","author":"Kekalainen","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0290","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jaut.2010.07.008","article-title":"Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3(+) precursors and impaired activated population","volume":"35","author":"Laakso","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2013.03.007_bb0295","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaut.2010.09.007","article-title":"The susceptibility of Aire(\u2212\/\u2212) mice to experimental myasthenia gravis involves alterations in regulatory T cells","volume":"36","author":"Aricha","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2013.03.007_bb0300","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/eji.201041253","article-title":"Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications","volume":"41","author":"Kisand","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0305","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.1.5958.600","article-title":"Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis","volume":"1","author":"Bucknall","year":"1975","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2013.03.007_bb0310","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2013.03.010","article-title":"Etiology of myasthenia gravis: Innate immunity signature in pathological thymus","volume":"12","author":"Cavalcante","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.007_bb0315","first-page":"597","article-title":"Pathologisch-anatomischer Beitrag zur Erb'schen Krankheit (myasthenia gravis)","volume":"20","author":"Weigert","year":"1901","journal-title":"Neurol Zentralbl"},{"key":"10.1016\/j.autrev.2013.03.007_bb0320","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.167.4.1935","article-title":"Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis","volume":"167","author":"Sims","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0325","first-page":"995","article-title":"The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat","volume":"139","author":"Meinl","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0330","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(77)92118-3","article-title":"Intrathymic pathogenesis and dual genetic control of myasthenia gravis","volume":"1","author":"Wekerle","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2013.03.007_bb0335","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/256493a0","article-title":"Striated muscle fibres differentiate in monolayer cultures of adult thymus reticulum","volume":"256","author":"Wekerle","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2013.03.007_bb0340","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.831257","article-title":"Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis","volume":"195","author":"Kao","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.autrev.2013.03.007_bb0345","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-5728(02)00038-3","article-title":"Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis","volume":"125","author":"Roxanis","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0350","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1073\/pnas.76.1.504","article-title":"Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors","volume":"76","author":"Weinberg","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2013.03.007_bb0355","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02889966","article-title":"Immunohistological patterns of non-neoplastic changes in the thymus in Myasthenia gravis","volume":"52","author":"Kirchner","year":"1986","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0360","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(78)90073-9","article-title":"In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis","volume":"1","author":"Vincent","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2013.03.007_bb0365","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJM197412122912403","article-title":"The thymus in myasthenia gravis. Evidence for altered cell populations","volume":"291","author":"Abdou","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2013.03.007_bb0370","first-page":"97","article-title":"Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis","volume":"58","author":"Willcox","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0375","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.4049\/jimmunol.1002539","article-title":"Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis","volume":"186","author":"Gomez","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0380","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(00)00415-X","article-title":"True epithelial hyperplasia in the thymus of early-onset myasthenia gravis patients: implications for immunopathogenesis","volume":"112","author":"Roxanis","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0385","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.4049\/jimmunol.157.8.3752","article-title":"Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis","volume":"157","author":"Wakkach","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0390","first-page":"447","article-title":"Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset?","volume":"127","author":"Willcox","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0395","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood-2005-06-2383","article-title":"The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis","volume":"108","author":"Meraouna","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.03.007_bb0400","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.21628","article-title":"CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia","volume":"66","author":"Berrih-Aknin","year":"2009","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.007_bb0405","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.imbio.2012.05.006","article-title":"SDF-1\/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients","volume":"218","author":"Weiss","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.autrev.2013.03.007_bb0410","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jneuroim.2006.05.023","article-title":"The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis","volume":"178","author":"Thangarajh","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0415","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0002-9440(10)62960-4","article-title":"Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution","volume":"167","author":"Bernasconi","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0420","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2013.03.011","article-title":"Ectopic germinal centers, BAFF and anti-B cell therapy in myasthenia gravis","volume":"12","author":"Berrih-Aknin","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.007_bb0425","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0165-5728(91)90165-4","article-title":"Antibodies to thymic epithelial cells in myasthenia gravis","volume":"35","author":"Safar","year":"1991","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0430","doi-asserted-by":"crossref","first-page":"e36603","DOI":"10.1371\/journal.pone.0036603","article-title":"Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population","volume":"7","author":"Maniaol","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2013.03.007_bb0435","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low\/-) T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0440","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004280050044","article-title":"Pathogenesis of myasthenia gravis","volume":"430","author":"Marx","year":"1997","journal-title":"Virchows Arch"},{"key":"10.1016\/j.autrev.2013.03.007_bb0445","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.03.007_bb0450","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.humimm.2011.12.022","article-title":"High prevalence of infections and autoimmunity in patients with thymoma","volume":"73","author":"Holbro","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0455","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1212\/WNL.65.5.782","article-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis","volume":"65","author":"Saka","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.007_bb0460","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.nmd.2008.06.368","article-title":"Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor","volume":"18","author":"Maggi","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.autrev.2013.03.007_bb0465","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2010.12.013","article-title":"Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies","volume":"302","author":"Rigamonti","year":"2011","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.autrev.2013.03.007_bb0470","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/WCO.0b013e328359da15","article-title":"Paraneoplastic neurological syndromes","volume":"25","author":"Graus","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0475","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics Tumours of the Lung, Pleura, Thymus and Heart","article-title":"Tumours of the thymus","author":"M\u00fcller-Hermelink","year":"2004"},{"key":"10.1016\/j.autrev.2013.03.007_bb0480","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood.V96.12.3872","article-title":"Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease","volume":"96","author":"Hoffacker","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.03.007_bb0485","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.1017","article-title":"Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0490","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","article-title":"Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis","volume":"22","author":"Strobel","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0495","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2009.12.036","article-title":"Aire, master of many trades","volume":"140","author":"Kyewski","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2013.03.007_bb0500","first-page":"331","article-title":"Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin","volume":"66","author":"Williams","year":"1992","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2013.03.007_bb0505","first-page":"194","article-title":"Thymomatous epithelial cells and skeletal muscle share a common epitope defined by a monoclonal antibody","volume":"126","author":"Dardenne","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0510","first-page":"1839","article-title":"Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis","volume":"148","author":"Marx","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0515","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0165-5728(02)00145-5","article-title":"Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules","volume":"128","author":"Romi","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0520","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(87)90032-8","article-title":"Acetylcholine receptor epitopes on epithelial cells of thymoma in myasthenia gravis","volume":"1","author":"Kirchner","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2013.03.007_bb0525","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1172\/JCI112069","article-title":"Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex","volume":"76","author":"Savino","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.03.007_bb0530","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1196\/annals.1405.018","article-title":"Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms","volume":"1132","author":"Strobel","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.007_bb0535","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archneur.62.3.442","article-title":"Striational antibodies in myasthenia gravis: reactivity and possible clinical significance","volume":"62","author":"Romi","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0540","first-page":"474512","article-title":"Thymoma in myasthenia gravis: from diagnosis to treatment","volume":"2011","author":"Romi","year":"2011","journal-title":"Autoimmun Dis"},{"key":"10.1016\/j.autrev.2013.03.007_bb0545","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2249.1990.tb05440.x","article-title":"Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin","volume":"82","author":"Aarli","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0550","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1212\/WNL.57.9.1579","article-title":"Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?","volume":"57","author":"Buckley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.007_bb0555","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","article-title":"Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis","volume":"132","author":"Meager","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0560","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJMc0909510","article-title":"Acquired autoimmune polyglandular syndrome, thymoma, and an AIRE defect","volume":"362","author":"Cheng","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2013.03.007_bb0565","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/intimm\/dxg088","article-title":"Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor","volume":"15","author":"Shiono","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0570","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9440(10)64536-1","article-title":"Recurrent genetic aberrations in thymoma and thymic carcinoma","volume":"157","author":"Zettl","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0575","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1074-7613(00)80283-6","article-title":"Positive and negative CD4+ thymocyte selection by a single MHC class II\/peptide ligand affected by its expression level in the thymus","volume":"6","author":"Fukui","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2013.03.007_bb0580","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2009.02.004","article-title":"Association of HLA-A in autoimmune myasthenia gravis with thymoma","volume":"210","author":"Vandiedonck","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0585","article-title":"The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity","author":"Gianchecchi","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.007_bb0590","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ana.20751","article-title":"Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis","volume":"59","author":"Vandiedonck","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0595","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/ana.20577","article-title":"A CTLA4high genotype is associated with myasthenia gravis in thymoma patients","volume":"58","author":"Chuang","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0600","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/gene.2009.64","article-title":"The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis","volume":"10","author":"Chuang","year":"2009","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2013.03.007_bb0605","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00415-012-6478-6","article-title":"Characteristics of late-onset myasthenia gravis","volume":"259","author":"Zivkovic","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0610","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1468-1331.2007.01785.x","article-title":"Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features","volume":"14","author":"Romi","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0615","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1196\/annals.1405.040","article-title":"Myasthenia gravis in the elderly: is it different?","volume":"1132","author":"Aarli","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.007_bb0620","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1196\/annals.1254.055","article-title":"Myasthenia gravis in individuals over 40","volume":"998","author":"Aarli","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2013.03.007_bb0625","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1468-1331.2002.00352.x","article-title":"Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis","volume":"9","author":"Romi","year":"2002","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.007_bb0630","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1468-1331.2012.03850.x","article-title":"Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996\u20132009","volume":"20","author":"Pedersen","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0635","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/25374","article-title":"Changes in thymic function with age and during the treatment of HIV infection","volume":"396","author":"Douek","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2013.03.007_bb0640","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jneuroim.2008.06.017","article-title":"The ageing and myasthenic thymus: a morphometric study validating a standard procedure in the histological workup of thymic specimens","volume":"201\u2013202","author":"Strobel","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0645","first-page":"347","article-title":"Thymic myoid cells and myasthenia gravis","volume":"59","author":"Van de Velde","year":"1970","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0650","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.57.9.1555","article-title":"Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies","volume":"57","author":"Giraud","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.007_bb0655","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10875-011-9617-4","article-title":"Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups","volume":"32","author":"Hapnes","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0660","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1210\/jc.2008-0935","article-title":"Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I","volume":"93","author":"Meloni","year":"2008","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0665","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2009.08.018","article-title":"Expanded TCR Vbeta subsets of CD8(+) T-cells in late-onset myasthenia gravis: novel parallels with thymoma patients","volume":"216","author":"Tackenberg","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0670","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/0891693031000084369","article-title":"CD45 isoform expression in autoimmune myasthenia gravis","volume":"36","author":"Tackenberg","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2013.03.007_bb0675","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2009.02.009","article-title":"Interleukin-10 promoter polymorphisms in myasthenia gravis","volume":"210","author":"Alseth","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0680","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/clim.1999.4710","article-title":"Correlation of thymic pathology with HLA in myasthenia gravis","volume":"91","author":"Machens","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0685","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.humimm.2006.02.039","article-title":"HLA-DQ polymorphism in Turkish patients with myasthenia gravis","volume":"67","author":"Saruhan-Direskeneli","year":"2006","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0690","first-page":"541760","article-title":"Association of HLA-DQB1 *05:02 and DRB1 *16 Alleles with Late-Onset, Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis","volume":"2012","author":"Testi","year":"2012","journal-title":"Autoimmun Dis"},{"key":"10.1016\/j.autrev.2013.03.007_bb0695","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.autrev.2013.03.005","article-title":"Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis","volume":"12","author":"Mori","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.007_bb0700","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00415-011-5964-6","article-title":"Familial autoimmune MuSK positive myasthenia gravis","volume":"258","author":"Corda","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0705","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/WCO.0b013e32833c0982","article-title":"Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis","volume":"23","author":"Guptill","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0710","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.WNL.0000150587.71497.B6","article-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis","volume":"64","author":"Lauriola","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2013.03.007_bb0715","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2013.03.007_bb0720","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/08916934.2011.611550","article-title":"T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients","volume":"45","author":"Oshima","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2013.03.007_bb0725","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.27435","article-title":"Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease","volume":"62","author":"Khosroshahi","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2013.03.007_bb0730","first-page":"744","article-title":"Recent insights into the role and molecular mechanisms of the autoimmune regulator (AIRE) gene in autoimmunity","volume":"10","author":"Fierabracci","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.007_bb0735","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.humimm.2009.04.027","article-title":"The autoimmunity-related polymorphism PTPN22 1858C\/T is associated with anti-titin antibody-positive myasthenia gravis","volume":"70","author":"Greve","year":"2009","journal-title":"Hum Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213000335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213000335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T14:04:06Z","timestamp":1688133846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997213000335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":147,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1568997213000335"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2013.03.007","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2013.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}